Infant Bacterial Therapeutics AB (publ)

BST:9IB Stock Report

Market Cap: €46.9m

Infant Bacterial Therapeutics Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

BST:9IB Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
14 Nov 24Buy€1,469Maria EkdahlIndividual500€2.94
02 Sep 24Buy€30,845Anthon JahreskogIndividual14,000€2.20
02 Sep 24Buy€2,247Maria EkdahlIndividual1,000€2.25
28 May 24Buy€1,303Maria EkdahlIndividual156€8.37
17 May 24Buy€2,251Anthon JahreskogIndividual270€8.38
13 May 24Buy€7,980Margareta HagmanIndividual1,000€7.98
10 May 24Buy€19,030Anthon JahreskogIndividual2,450€7.88
10 May 24Buy€1,539Eva IdénIndividual200€7.69
04 Mar 24Buy€3,272Anthon JahreskogIndividual460€7.11
08 Feb 24Buy€8,336Anthon JahreskogIndividual1,000€8.34

Insider Trading Volume

Insider Buying: 9IB insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of 9IB?
Owner TypeNumber of SharesOwnership Percentage
Individual Insiders530,7293.94%
Private Companies1,174,6348.72%
General Public4,018,90829.8%
Institutions7,747,14957.5%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top Shareholders

Top 25 shareholders own 70.16% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
11%
SIX Group AG, Asset Management Arm
1,480,423€5.2m0%0.95%
9.98%
Fourth Swedish National Pension Fund (AP4)
1,344,000€4.7m0%0.02%
8.72%
Annwall & Rothschild Investments Ab
1,174,634€4.1m0%no data
8.32%
Northern Trust Global Investments
1,121,425€3.9m0%no data
4.94%
Keel Capital AB
666,053€2.3m0%6.34%
4.47%
AMF Fonder AB
601,902€2.1m0%0.01%
4.25%
Premier Fund Managers Ltd.
573,153€2.0m0%0.03%
3.95%
Unionen, Endowment Arm
532,023€1.9m0%0.57%
3.29%
SEB Investment Management AB
443,250€1.5m0%no data
3.04%
Ålandsbanken Asset Management Ab
409,104€1.4m0%1.44%
2.76%
Tredje AP-fonden
371,774€1.3m0%0.01%
2.73%
David Dangoor
367,705€1.3m0%no data
0.79%
Staffan Stromberg
106,910€372.1k0%no data
0.57%
Handelsbanken Asset Management
76,687€266.9k0%no data
0.3%
Schroder Investment Management Limited
40,000€139.2k0%no data
0.28%
Marathon Asset Management Limited
37,434€130.3k-21.5%no data
0.25%
FCG Fonder AB
34,284€119.3k0%0.01%
0.18%
Anthon Jahreskog
24,270€84.5k136%no data
0.083%
Anders Kronström
11,194€39.0k0%no data
0.074%
Robert Molander
10,000€34.8k0%no data
0.063%
Skandia Fonder AB
8,432€29.3k0%no data
0.043%
Storebrand Fonder AB,
5,848€20.4k0%no data
0.039%
Margareta Hagman
5,284€18.4k0%no data
0.035%
Maria Ekdahl
4,706€16.4k11.9%no data
0.0074%
Dimensional Fund Advisors LP
1,000€3.5k0%no data

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/02/04 15:56
End of Day Share Price 2025/01/09 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Infant Bacterial Therapeutics AB (publ) is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution